Effectiveness of a 6-week Specific Rehabilitation Program on Walking Capacity in Patients with Lumbar Spinal Stenosis
Launched by UNIVERSITÉ DU QUÉBEC À TROIS-RIVIÈRES · Aug 22, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a 6-week rehabilitation program designed to help people with lumbar spinal stenosis, a condition that narrows the spine and can cause pain and difficulty walking. The trial aims to see if combining education and specific exercises can improve walking ability compared to just receiving education. Participants will be assessed at different points during the study to see how their walking capacity and other factors like pain and overall health change over time.
To be eligible for this study, participants should be at least 50 years old and have been experiencing symptoms of spinal stenosis for at least three months. They should be able to walk at least 20 meters without help but struggle to walk continuously for 30 minutes. The program involves attending sessions three times a week, where participants will learn and practice exercises. It's important to note that certain health conditions, like severe arthritis or recent surgeries, may disqualify someone from participating. Overall, this trial could be a valuable opportunity for those looking to improve their walking ability and manage their symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • being at least 50 years old
- • having a degenerative central LSS alone or in combination with other LSS types (e.g. foraminal, lateral) and/or a spondylolisthesis affecting one or multiple vertebral levels, confirmed by clinical history, physical examination and proper imaging
- • having NC associated with LSS
- • being able to speak and understand French
- • being willing to attend 3 intervention sessions per week
- • with a duration of signs and symptoms of at least 3 months
- • (7) being able to walk at least 20 meters without walking aid, but not being able to walk continuously for 30 minutes
- • being able to provide informed written consent.
- Exclusion Criteria:
- • congenital LSS,
- • symptomatic osteoarthritis (hip or knee) causing limited walking capacity
- • neurological disease affecting walking capacity such as Parkinson
- • uncontrolled diabetes
- • heart failure
- • intermittent claudication of vascular origin
- • impaired cognitive capacity
- • back or lower extremities surgery in the past 3 months
About Université Du Québec à Trois Rivières
Université du Québec à Trois-Rivières (UQTR) is a leading academic institution dedicated to advancing research and education in various fields, including health sciences. With a commitment to innovation and interdisciplinary collaboration, UQTR fosters an environment conducive to groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university's robust research infrastructure and skilled faculty support the design and implementation of high-quality clinical studies, ensuring adherence to ethical standards and regulatory compliance. UQTR's involvement in clinical trials underscores its mission to contribute significantly to scientific knowledge and the betterment of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trois Rivières, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials